T-Cell Vaccination in Multiple Sclerosis (MS)

COVID-19 Vaccine Response in Treated MS Patients

NCT05060354 ·Status: COMPLETED

Study to Investigate the Immune Response and Safety of Prophylactic Vaccines in Patients Treated for Multiple Sclerosis

NCT02275741 ·Status: COMPLETED

Covid-19 Vaccine Immune Response in Multiple Sclerosis

NCT05269888 ·Status: ACTIVE_NOT_RECRUITING

T Cell Profiling in Patients with Multiple Sclerosis

NCT04789551 ·Status: NOT_YET_RECRUITING

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

NCT06735248 ·Status: RECRUITING ·Phase: PHASE2

Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication

NCT04796584 ·Status: TERMINATED

Mesenchymal Stem Cells for Multiple Sclerosis

NCT01730547 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis

NCT04823000 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple Sclerosis

NCT00087529 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Characterization of White Blood Cells Sub-populations From Multiple Sclerosis Patients.

NCT03486665 ·Status: UNKNOWN

Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis

NCT05116540 ·Status: COMPLETED ·Phase: PHASE2

Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis

NCT02166021 ·Status: COMPLETED ·Phase: PHASE2

Trial to Assess the Safety and Feasibility of Adoptive Cell Therapy with Autologous EBV-specific Cytotoxic T Lymphocytes (CTL) in Patients with a First Clinical Episode Highly Suggestive of Multiple Sclerosis

NCT02912897 ·Status: RECRUITING ·Phase: PHASE1

The Effects of Tysabri Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis

NCT00536120 ·Status: COMPLETED ·Phase: PHASE4

RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis

NCT07006805 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)

NCT06675864 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

MUltiple Sclerosis : T Cell / B Cell Exploration

NCT04231253 ·Status: COMPLETED

Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients

NCT02142764 ·Status: COMPLETED ·Phase: NA

Immunisation Status and Safety of Vaccines in Italian MS Patients

NCT04300868 ·Status: UNKNOWN

A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668

NCT02313285 ·Status: COMPLETED

NOGO-A in Multiple Sclerosis FTIH

NCT01424423 ·Status: TERMINATED ·Phase: PHASE1

Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients

NCT00220493 ·Status: UNKNOWN ·Phase: PHASE1

COMparison Between All immunoTherapies for Multiple Sclerosis.

NCT03193866 ·Status: COMPLETED

A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis

NCT02545868 ·Status: COMPLETED ·Phase: PHASE3

Autologous T Cell Vaccine (TCV) for Multiple Sclerosis

NCT00245622 ·Status: COMPLETED ·Phase: PHASE2